Literature DB >> 8280051

Immobilized pH gradient focusing of alkaline proteins: analysis of the isoform composition of purified human non-secretory ribonucleases from kidney, liver and spleen.

E C Coronel1, B W Little, J A Alhadeff.   

Abstract

Previous studies on the isoform composition of human ribonucleases (RNAases) have resulted in confusing and inconsistent results, presumably due to methodological problems in electrofocusing of alkaline proteins. In the present study, immobilized pH gradient (IPG) carrier ampholyte (CA) isoelectric focusing (IEF) and conventional CA-IEF have been evaluated for the analysis of the isoforms of human non-secretory RNAases purified from kidney, liver and spleen. CA-IEF proved unsuitable since the alkaline RNAase isoforms migrated into the cathode. IPG-CA-IEF, however, resolved the RNAase isoforms and marker proteins in the basic region of the gel matrix. The three RNAases had comparable isoform profiles, each with two protein bands with approximate pI values of 10.3 and 10.4. Western blotting showed that the two protein bands of each RNAase were immunoreactive (with polyclonal antibodies that recognize RNAase), indicating that the protein bands are RNAase isoforms. The present results provide reliable pI data on human RNAase isoforms and suggest that IPG-CA-IEF should be a suitable technique for analysing the isoforms of other alkaline proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280051      PMCID: PMC1137733          DOI: 10.1042/bj2960553

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Fast and sensitive protein staining with colloidal acid violet 17 following isoelectric focusing in carrier ampholyte generated and immobilized pH gradients.

Authors:  N P Patestos; M Fauth; B J Radola
Journal:  Electrophoresis       Date:  1988-09       Impact factor: 3.535

2.  Small-scale fractionation of proteins and nucleic acids by isoelectric focusing in polyacrylamide gels.

Authors:  P G Righetti; J W Drysdale
Journal:  Ann N Y Acad Sci       Date:  1973-06-15       Impact factor: 5.691

3.  Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications.

Authors:  B Bjellqvist; K Ek; P G Righetti; E Gianazza; A Görg; R Westermeier; W Postel
Journal:  J Biochem Biophys Methods       Date:  1982-09

4.  Amino acid sequence of human tumor derived angiogenin.

Authors:  D J Strydom; J W Fett; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

5.  New detection method for ribonuclease 2 (RNase 2) using immunoblotting with specific antibody.

Authors:  K Mizuta; T Yasuda; Y Ikehara; W Sato; K Kishi
Journal:  Z Rechtsmed       Date:  1990

6.  Amino acid sequence of the nonsecretory ribonuclease of human urine.

Authors:  J J Beintema; J Hofsteenge; M Iwama; T Morita; K Ohgi; M Irie; R H Sugiyama; G L Schieven; C A Dekker; D G Glitz
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

7.  Purification and immunological characterization of human pancreatic ribonuclease.

Authors:  M Kurihara; M Ogawa; T Ohta; E Kurokawa; T Kitahara; G Kosaki; T Watanabe; H Wada
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

8.  Purification and properties of ribonucleases from human urine.

Authors:  J W Cranston; F Perini; E R Crisp; C V Hixson
Journal:  Biochim Biophys Acta       Date:  1980-12-04

9.  Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.

Authors:  R L Barker; D A Loegering; R M Ten; K J Hamann; L R Pease; G J Gleich
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

10.  Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.

Authors:  G J Gleich; D A Loegering; M P Bell; J L Checkel; S J Ackerman; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.